Evaluation of 144 risk factors across 39 cancer types identified 2,388 risk-cancer associations, with 92.4% of the identified risk factors being modifiable.
Meta-Analysis
An AI-driven meta-analysis successfully mapped 2,388 associations between 144 risk factors and 39 cancer types, demonstrating high consistency with published meta-analyses.
Abstract Background: A comprehensive understanding of the associations between multiple risk factors and cancer incidence is crucial for evidence-based cancer control. While many studies have examined specific risk-cancer pairs, none have yet estimated the entire network of risks across cancer types. This study aims to quantity the associations between 144 cancer-related risk factors and the incidence of 39 cancer types. Methods: Using risk records from CanRisk-DB, a well-established repository that employs graph-based retrieval-augmented generation large language model agents within the PICOS-PRISMA framework, we synthesized relative risks (RRs) or hazard ratios (HRs) of cancer incidence from cohort studied between 1980 and 2024. We meta-analyzed the effect sizes using harmonized definitions and both graph-based and inverse variance approaches. The reliability of this artificial intelligence (AI)-driven meta-analysis was validated by comparing our estimated effects with those from published meta-analyses. Results: A total of 2,388 combinations between 144 risk factors and 39 cancer types were identified from CanRisk-DB. Among these, 131 and 120 risk factors were linked to 36 and 33 cancer types in females and males, respectively. Of 144 risk factors, 92.4% were modifiable. 67 factors were identified as causal risk factors only, such as family history of cancer, immunosuppressive agents, non-alcoholic fatty liver disease, and nitrogen dioxide pollution. However, 77 risk factors showed either causal and protective roles across cancer types, such as tobacco use, alcohol consumption, and type 2 diabetes. For instance, alcohol consumption was positively associated with several cancers (e.g., liver RR = 1.46; 95% CI, 1.27-1.69, breast RR = 1.09; 95% CI, 1.06-1.12, and colorectal RR = 1.08; 95% CI, 1.02-1.13) but inversely with kidney cancer (RR = 0.81; 95% CI, 0.76-0.87). The cancers with the greatest number of associated risk factors were lung (73 factors), colorectal (57), and liver (53). Overall, the majority of cancer types were associated with multiple modifiable risk factors: 34 cancers (87.2%) with at least 5 risks, 28 cancers (71.8%) with at least 10 risks, and 20 cancers (51.3%) with at least 15 risks. The effect sizes in our analysis are highly consistent with those reported in published meta-analyses (Spearman’s ρ = 0.93). Conclusion: AI-driven systematic reviews and meta-analyses accurately captured the complex network of associations between cancers and risk factors. Mapping these relationships facilitated a better understanding of the attributable risk of cancer, thereby informing strategies for cancer prevention and control. Citation Format: Changfa Xia, Shiyuan Tong, Yongjie Xu, Hui Yu, Fang Liu, Shiqing Chen, Fei Zhao, Junyi Ye, Jing Liu, Baoliang Zhu, Xiaohui Wu, Sibo Zhu, Wanqing Chen. Mapping the associations of 144 incidence risk factors with 39 cancers: An AI-driven systematic review and meta-analysis abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2337.
Xia et al. (Fri,) conducted a meta-analysis in Cancer. 144 incidence risk factors was evaluated on Cancer incidence. Evaluation of 144 risk factors across 39 cancer types identified 2,388 risk-cancer associations, with 92.4% of the identified risk factors being modifiable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: